Schedule 13G ownership disclosure

REGENXBIO Inc

Common Stock, par value $0.0001 per share · CUSIP: 75901B107

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Redmile Group, LLC

    Shares: 5,062,477.00 · Class: 9.9%

  • Jeremy C. Green

    Shares: 5,062,477.00 · Class: 9.9%

  • Redmile Biopharma Investments III, L.P.

    Shares: 3,733,796.00 · Class: 7.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-078638
Form type
SCHEDULE 13G/A
Filer
REGENXBIO Inc.
CIK
CIK 1590877
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub